Recorded Events
Post-IAS Webinar with Discussion of Application to Clinical Practice
Watch on demand our discussion on ViiV-sponsored data presented at the 2023 IAS Conference with a panel discussion.Women’s PrEP Disparity Webinar with Expert Panel Discussion
Kimberly Smith, MD, MPHSVP and Head, Research & Development
ViiV Healthcare
Toyin Nwafor, MD
Sr. Medical Director, HIV Prevention
ViiV Healthcare
Heidi Swygard. MD, MPH
Regional Medical Lead, PrEP
ViiV Healthcare
POST CROI 2023 Webinar
Expert Panel Discussion of 2023 CROI ViiV-Sponsored DataPOST AIDS 2022 Webinar
Expert Panel Discussion of 2022 AIDS ViiV-Sponsored DataUtilizing and Applying Findings from Observational Studies in AIDS Research
Shelly Dhir, PharmD Sr. Director, Portfolio Medical LeadDr. Rick Elion, MD Director of Clinical Research, Washington Health Institute and Clinical Professor of Medicine George Washington University School of Medicine
Using Fewer HIV Treatments When Treating HIV Long Term
Andrew Zolopa, MD VP, Head, North American Medical Affairs ViiV HealthcareDr. Babafemi Taiwo, MD, MBBS Gene Stollerman Professor of Medicine and Chief of the Division of Infectious Diseases Northwestern University
Discussing CABENUVA Data at AIDS 2022
Bruce Gilliam, MD, FACP Sr. Medical Director, North American Medical AffairsDr. Moti Ramgopal, MD, FIDSA, FACP Associate Professor of Medicine Medical Director Midway Research Center and Found of Midway Specialty Care Centers
Discussing the BRIGHTE Study at AIDS 2022
Bruce Gilliam, MD, FACP Sr. Medical Director, North American Medical AffairsDr. Moti Ramgopal, MD, FIDSA, FACP Associate Professor of Medicine Medical Director Midway Research Center and Found of Midway Specialty Care Centers
Caring for Patients with Multidrug Resistant (MDR) HIV - A Focus on Patient Identification and ARV Management with Q&A
Alftan Dyson, PharmD | Bruce Gilliam, MD | Elizabeth Race, MD, MPH| Moti Ramgopal, MD, FACP, FIDSAPost Fall Conference 2021 Webinar
Dr. Andrew Zolopa, ViiV Medical ExpertsPost-IAS 2021 Webinar
Dr. Andrew Zolopa, ViiV Medical ExpertsThe ABCs of CAB: Incorporating Long-Acting Cabenuva into Clinical Practice
Paula Teichner, PharmD, AAHIVP, Regional Medical LeadPost-CROI 2021 Webinar
Andrew Zolopa, MD, VP, Head, North America Medical AffairsSTAT 24 Week: Feasibility, Efficacy and Safety
Jean Van Wyk, MBChB, Global Medical Lead, DolutegravirTANGO 96 Week: Efficacy and Safety
Jean Van Wyk, MBChB, Global Medical Lead, DolutegravirGEMINI 144 Week: Efficacy and Safety
Jean Van Wyk, MBChB, Global Medical Lead, DolutegravirGEMINI 48 Week: Adherence Analysis
Jean Van Wyk, MBChB, Global Medical Lead, DolutegravirAre you a US healthcare provider?
This web portal is intended as an educational resource for healthcare providers practicing in the United States. It may include information about products or uses that have not been approved by the US Food and Drug Administration.
If you are not a healthcare provider, please discuss any questions you have regarding your health or medicines with your doctor, pharmacist, or nurse.
Connect With Our Medical Experts
Find My ViiV MSL
Easily find the ViiV Medical Science Liaison (MSL) in your area.
Talk to a Medical Expert
Connect now with a live ViiV Medical Expert.
Request a Scientific Discussion
Submit a request for additional information from a ViiV Medical Expert.
Contact Us
Chat Live
Get immediate assistance from a ViiV Healthcare Professional.
Call 1‑888‑226‑8434
Weekdays from 8 AM to 6 PM ET
(5 AM – 3 PM PT)
Report an Adverse Event
To report SUSPECTED ADVERSE REACTIONS, contact ViiV Healthcare at 1‑877‑844‑8872 or FDA at 1‑800‑332‑1088 or www.fda.gov/medwatch